Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers

European Addiction Research

Volumn 15, Issue 3, 2009, Pages 150-156

  Winklbaur, Bernadette ^a   Baewert, Andjela ^a   Jagsch, Reinhold ^c   Rohrmeister, Klaudia ^b   Metz, Verena ^a   Jachmann, Crispa Aeschbach ^a   Thau, Kenneth ^a   Fischer, Gabriele ^a,b  

^a Department of Psychiatry and Psychotherapy ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Drug dependence; Fetal nicotine exposure; Neonatal abstinence syndrome; Neonatal outcome; Opioid maintenance therapy; Pregnancy; Slow release oral morphine

Indexed keywords

AMPHETAMINE; BENZODIAZEPINE; BUPRENORPHINE; COCAINE; METHADONE; MORPHINE; TOBACCO SMOKE;

ADOLESCENT; ADULT; ADVERSE OUTCOME; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BREATHING; BREATHING RATE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CRYING; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG USE; FAILURE TO THRIVE; FEEDING; FEMALE; FEVER; GRAND MAL SEIZURE; HEAD CIRCUMFERENCE; HEART RATE; HUMAN; IRRITABILITY; LENGTH OF STAY; LOOSE FECES; MAJOR CLINICAL STUDY; MUSCLE TONE; NEWBORN; NOSE CONGESTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; REFLEX; SKIN COLOR; SLEEP; SNEEZING; SUCKING; SWEATING; TACHYPNEA; TOBACCO DEPENDENCE; TREMOR; VOMITING; WITHDRAWAL SYNDROME; YAWNING;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; BIRTH WEIGHT; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; SMOKING; YOUNG ADULT;

EID: 65449156076     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000216466     Document Type: Article

References (35)

1. Windsor RA, Boyd NR, Orleans CT: A meta evaluation of smoking cessation intervention research among pregnant women: improving the science and art. Health Educ Res 1998;13:419-438.
2. Tuthill DP, Steward JH, Coles EC, Andrews J, Cartlidge PH: Maternal cigarette smoking and pregnancy outcome. Paediatr Perinat Epidemiol 1999;13:245-253.
3. Law KL, Stroud LR, LaGasse LL, Niaura R, Lui J, Lester BM: Smoking during pregnancy and newborn neurobehaviour. Pediatrics 2003;111:1318-1323.
4. Higgins ST, Heil SH, Solomon LJ, Bernstein IM, Lussier JP, Abel RL, Lynch ME, Badger GJ: A pilot study on voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum. Nicotine Tob Res 2004;6:1015-1020.
5. Choo RE, Huestis MA, Schroeder JR, Shin AS, Jones HE: Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend 2004;75:253-260.
6. Matturri L, Ottaviani G, Lavezzi AM: Maternal smoking and sudden infant death syndrome: epidemiological study related to pathology. Virchows Arch 2006;449:697-706.
7. Sha T, Sullivan K, Carter J: Sudden infant death syndrome and reported maternal smoking during pregnancy. Am J Public Health 2006;96:1757-1759.
8. Ates U, Ata B, Armagan F, Has R, Sidal B: Acute effects of maternal smoking on fetal hemodynamics. Int J Gynaecol Obstet 2004;87: 14-18.
9. Somm E, Schwitzgebel VM, Vauthay DM, Camm EJ, Chen CY, Giacobino JP, Sizonen- ko SV, Aubert ML, Hüppi PS: Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology 2008; 149: 6289-6299.
10. Hill SY, Shen S, Locke Wellman J, Rickin E, Lowers L: Offspring from families at high risk for alcohol dependence: increased body mass index in association with prenatal exposure to cigarettes but not alcohol. Psychiatry Res 2005;135:203-216.
11. Levin ED, Slotkin TA: Developmental neu- rotoxicity of nicotine; in Slikker W, Chang LW (eds): Handbook of Developmental Neu- rotoxicity. New York, Academic Press, 1998,pp 587-615.
12. Garcia-Algar O, Puig C, Mendez C, Vall O, acifici R, Pichini S: Neonatal nicotine withdrawal syndrome. J Epidemiol Community Health 2001;55:687-688.
13. Jacobsen LK, Slotkin TA, Mencel WE, Frost J, Pugh KR: Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. Neuropharmacology 2007;32: 2453-2464.
14. McCartney JS, Fried PA, Watkinson B: Central auditory processing in school-age children prenatally exposed to cigarette smoke.Neurotoxicol Teratol 1994; 16: 269-276.
15. Noland JS, Singer LT, Short EJ, Minnes S, Arendt RE, Kirchner HL, Bearer C: Prenatal drug exposure and selective attention in preschoolers. Neurotoxicol Teratol 2005; 27:429-438.
16. Finnegan LP: Treatment issues for opioid- dependent women during the perinatal period. J Psychoactive Drugs 1991;23:191-201.
17. Fischer G, Johnson RE, Eder H, Jagsch R, Pe- ternell A, Weninger M, Langer M, Aschauer H: Treatment of opioid-dependent pregnant women with buprenorphine. Addiction 2000;95: 239-244.
18. Kaltenbach K, Finnegan LP: Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehav Toxicol Teratol 1986; 8: 353-355.
19. Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, Aschauer H: Meth- adone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 2006;101:275-281.
20. Fischer G, Jagsch R, Eder H, Gombas W, Etzersdorfer P, Schmidl-Mohl K, Schatten C, Weninger M, Aschauer H: Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 1999;94:231-239.
21. Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jagsch R, Peternell A, Thau K, Fischer G: Management of neonatal absti nence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2007;87:131-138.
22. Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chrisholm CA, et al: Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005;79:1-10.
23. Gsellhofer B, Küfner H, Vogt M, Weiler D: European Addiction Index - Manual für Training und Durchführung. Battmanns- weiler, Schneider, 1999.
24. Finnegan LP, Kaltenbach K: Neonatal abstinence syndrome; in Hoekelman RA, Fried SB, Nelson N, Seidl HM (eds): Primary Pedi- atric Care, ed 2. St. Louis, Mosby, 1992, pp1367-1378.
25. Rohrmeister K, Bernert G, Langer M, Fischer G, Weninger M, Pollak A: Opiate addiction in gravidity - consequences for the newborn. Results of an interdisciplinary treatment concept (in German). Z Geburtshilfe Neona-tol 2001; 205: 224-230.
26. Finnegan LP: Neonatal abstinence; in Nelson NM (ed): Current Therapy in Neonatal- Perinatal Medicine. St. Louis, Mosby, 1985,p 262.
27. Battino D, Estienne M, Avanzino G: Clinical pharmacokinetics of antiepileptic drugs in pediatric patients. Clin Pharmacokinet 1995;29: 257-286.
28. Sarenmaa E, Huttunen P, Leppäluoto J, Meretoja O, Fellman V: Advantages of fen- tanyl over morphine in analgesia for ventilated newborn infants after birth: a randomised trial. J Pediatr 1999; 134:144-150.
29. Lambers DS, Clark KE: The maternal and fetal physiologic effects of nicotine. Semin Perinatol 1996;20:115-126.
30. Kaltenbach K, Finnengan L: Perinatal and developmental outcome of infants exposed to methadone in-utero. Neurotoxicol Teratol 1987;9:311-313.
31. Coleman T: ABC of smoking cessation. Use of simple advice and behavioral support.BMJ 2004; 328: 397-399.
32. Chan B, Einarson A, Koren G: Effectiveness of bupropion for smoking cessation during pregnancy. J Addict Dis 2005; 24:19-23.
33. Rayburn WF, Bogenschutz MP: Pharmaco- therapy for pregnant women with addictions. Am J Obstet Gynecol 2004; 191:1885-1897.
34. Keating GM, Siddiqui MAA: Varenicline: a review of its use as an aid to smoking cessation therapy. CNS Drugs 2006; 20: 945-960.
35. Prochazka AV: New developments in smoking cessation. Chest 2000; 117:169-175.